Form 4: VolitionRx Executive Jacob Vincent Micallef Reports Changes in Beneficial Ownership
SEC Form 4 Filing
Jacob Vincent Micallef, Chief Scientific Officer of VolitionRx, reports changes in beneficial ownership of company stock due to tax withholding obligations.
Summary
- On September 28, 2024, Jacob Vincent Micallef, the Chief Scientific Officer of VolitionRx Ltd, had 4,950 shares of common stock withheld by the company to cover tax obligations upon the settlement of 12,375 restricted stock units.
- The shares were withheld at a price of $0.578 per share.
- Following the transaction, Micallef directly owns 355,861 shares of VolitionRx common stock.
- Micallef also indirectly owns 55,000 shares through his spouse and 38,113 shares through Borlaug Limited, where he is a controlling director.
Sentiment
Score: 5
Explanation: This is a neutral filing related to standard executive compensation and tax obligations. It doesn't inherently indicate positive or negative sentiment.
Industry Context
Form 4 filings are a routine part of compliance for company insiders and provide transparency into their transactions in company stock. This filing indicates activity related to tax obligations from vested restricted stock units.
Key Dates
| Date | Description |
|---|---|
| 09/28/2024 | Date of transaction where shares were withheld for tax obligations. |
| 10/01/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.